Influenza vaccine CPT codes for exposure identification
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.46Copied!
Version20211123Copied!
PublisherBEST System StewardDate2021-11-23T01:02:02-05:00Purpose(Clinical Focus: Influenza vaccine CPT codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: Influenza vaccine CPT codes.),(Exclusion Criteria: None)
Expansion
| Code | Display | System |
|---|---|---|
| 90658 | http://www.ama-assn.org/go/cpt | |
| 90653 | http://www.ama-assn.org/go/cpt | |
| 90688 | http://www.ama-assn.org/go/cpt | |
| 90667 | http://www.ama-assn.org/go/cpt | |
| 90666 | http://www.ama-assn.org/go/cpt | |
| 90656 | http://www.ama-assn.org/go/cpt | |
| 90674 | http://www.ama-assn.org/go/cpt | |
| 90685 | http://www.ama-assn.org/go/cpt | |
| 90660 | http://www.ama-assn.org/go/cpt | |
| 90655 | http://www.ama-assn.org/go/cpt | |
| 90661 | http://www.ama-assn.org/go/cpt | |
| 90673 | http://www.ama-assn.org/go/cpt | |
| 90756 | http://www.ama-assn.org/go/cpt | |
| 90686 | http://www.ama-assn.org/go/cpt | |
| 90694 | http://www.ama-assn.org/go/cpt | |
| 90668 | http://www.ama-assn.org/go/cpt | |
| 90672 | http://www.ama-assn.org/go/cpt | |
| 90657 | http://www.ama-assn.org/go/cpt | |
| 90664 | http://www.ama-assn.org/go/cpt | |
| 90630 | http://www.ama-assn.org/go/cpt |
systemhttp://www.ama-assn.org/go/cpt
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://www.ama-assn.org/go/cpt",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 25
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2021-11-23T01:02:02-05:00",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "BEST System Steward",
"jurisdiction" : [ {
"coding" : [ {
"system" : "urn:iso:std:iso:3166",
"code" : "US"
} ]
} ],
"purpose" : "(Clinical Focus: Influenza vaccine CPT codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: Influenza vaccine CPT codes.),(Exclusion Criteria: None)",
"name" : "InfluenzaVaccineCPTCodesForExposureIdentification",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90630",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90653",
"display" : "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90654",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90655",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90656",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90657",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90658",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90660",
"display" : "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90661",
"display" : "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90662",
"display" : "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90664",
"display" : "Influenza virus vaccine, live (LAIV), pandemic formulation, for intranasal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90666",
"display" : "Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90667",
"display" : "Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90668",
"display" : "Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90672",
"display" : "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90673",
"display" : "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90674",
"display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90682",
"display" : "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90685",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90686",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90687",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90688",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90694",
"display" : "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90756",
"display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
} ],
"total" : 24,
"identifier" : "urn:uuid:e7c440d6-1f09-4264-ac1a-d6257cafda4f",
"timestamp" : "2024-04-23T12:22:13-04:00"
},
"title" : "Influenza vaccine CPT codes for exposure identification",
"extension" : [ {
"valueString" : "BEST System Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2022-12-15",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2021-11-23",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "7d2dda62-197b-4db2-9277-90884a069d24",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.46",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1234.46"
} ],
"version" : "20211123"
}